BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 5993561)

  • 1. [Value of the clinical use of proscillaridin A].
    Ratti G; Rocca F; Savastano A
    Clin Ter; 1966 Sep; 38(5):413-24. PubMed ID: 5993561
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical use of a new cardioactive glycoside: proscillaridin A. Case studies].
    Pagliara R
    Minerva Med; 1967 Dec; 58(96):4296-301. PubMed ID: 6081717
    [No Abstract]   [Full Text] [Related]  

  • 3. [Some clinical observations on the use of a cardiokinetic extract of squill: proscillaridin A. Differences from other more commonly used glycosides].
    Luise A
    Minerva Med; 1967 Dec; 58(96):4286-9. PubMed ID: 6083290
    [No Abstract]   [Full Text] [Related]  

  • 4. [Contribution to the konwledge of some effects of proscillaridin on the cardiovascular system. Electrocardiographic and radiocardiographic research].
    Sorrentino F; Musco A; Cascone O; Modica G
    Clin Ter; 1966 Jul; 38(1):39-48. PubMed ID: 5990470
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical evaluation of Proscillaridin A, a glycoside of Scilla maritima].
    Kedra M; Kedrowa S
    Pol Tyg Lek; 1968 May; 23(19):714-6. PubMed ID: 4876207
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of the sugar component in cardiac glycosides on their action in patients with auricular fibrillation and congestive failure.
    Gold H; Kwit NT; Shane SJ; Dayrit C
    J Clin Pharmacol J New Drugs; 1969; 9(3):148-54. PubMed ID: 5255179
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical-experimental study on the characterization of a cardiac glycoside].
    Hänel J; Meiffert G
    Med Welt; 1966 Jun; 26():1404-8. PubMed ID: 5962714
    [No Abstract]   [Full Text] [Related]  

  • 8. [Quantitative therapy with cardiac glycosides].
    Storz H
    Med Welt; 1966 Aug; 35():1802-8. PubMed ID: 5975346
    [No Abstract]   [Full Text] [Related]  

  • 9. [Early identification of the electrocardiographic signs of digitalis overdosage].
    Kleinerman L; Dumitrescu O; Cionca H; Lecca S
    Med Interna (Bucur); 1970 Jun; 22(6):737-74. PubMed ID: 5456195
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of cardiac glycosides on the statistical distribution of R-R ventricular distances in complete arrhythmia].
    Pedich W; Antoniuk Z
    Pol Arch Med Wewn; 1967; 39(4):449-57. PubMed ID: 5582668
    [No Abstract]   [Full Text] [Related]  

  • 11. [The effect of cardiac glycosides on the diastole of the heart].
    Storz H
    Dtsch Med Wochenschr; 1970 Jan; 95(5):224-7. PubMed ID: 5410907
    [No Abstract]   [Full Text] [Related]  

  • 12. [Experiences with the cardiac glycoside Proscillaridin A (Sandoscill)].
    Amirfallah A; Einert HJ
    Munch Med Wochenschr; 1967 Aug; 109(33):1690-2. PubMed ID: 5631640
    [No Abstract]   [Full Text] [Related]  

  • 13. [Proscillardin A in the treatment of cardiocirculatory insufficiency. Clinco-experimental contribution].
    Bellomo A; Strobbia R; Lalloni R; Dalzotto U
    Minerva Med; 1967 Dec; 58(96):4246-62. PubMed ID: 6083286
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical action of a new cardioactive glycoside: proscillaridin A].
    Facci M
    Minerva Med; 1967 Dec; 58(96):4276-86. PubMed ID: 6083289
    [No Abstract]   [Full Text] [Related]  

  • 15. [Indications, contra-indications and dosage of cardiac glycosides controlled by plasma levels in the aged].
    Hötter GJ
    Z Gerontol; 1987; 20(1):8-12. PubMed ID: 3577317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical experiences with a squill preparation (proscillaridin A) in oral administration].
    Rosini E; Petacchi R
    Minerva Med; 1967 Dec; 58(96):4301-18. PubMed ID: 6083292
    [No Abstract]   [Full Text] [Related]  

  • 17. [Action of actodigin (AY-22,241) in patients with cardiac insufficiency and chronic auricular fibrillation or flutter].
    Bojorges R; Cárdenas M; Pastelín G; Mendez R
    Arch Inst Cardiol Mex; 1974; 44(4):615-23. PubMed ID: 4847978
    [No Abstract]   [Full Text] [Related]  

  • 18. [Unfavourable cardiovascular effects of propranolol].
    Lega P; Milazzotto F
    Clin Ter; 1968 Jun; 45(5):461-8. PubMed ID: 5737086
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical experience with the new cardiac glycoside peruvosid].
    Pfund WD
    Hippokrates; 1969 Aug; 40(16):646-53. PubMed ID: 5810178
    [No Abstract]   [Full Text] [Related]  

  • 20. [The cardiac glycoside treatment of circulatory insufficiency in the bradysystolic form of cardiac fibrillation].
    Dolgoplosk NA; Bazilevich MS
    Ter Arkh; 1967 Sep; 39(9):57-60. PubMed ID: 5611705
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.